Revium Rx (RVRC) Equity Ratio (2024 - 2025)
Revium Rx recorded quarterly Equity Ratio of 0.83 in Q4 2025, down 14.63% quarter-over-quarter from 0.97 in Q4 2024, and down 14.63% year-over-year from 0.97 in Q4 2024.
Revium Rx's Equity Ratio history runs 2 years deep, the most recent figure standing at 0.83 for Q4 2025.
- In Q4 2025, Equity Ratio fell 14.63% year-over-year to 0.83; the TTM figure through Dec 2025 stood at 0.83 (down 14.63% YoY), while the FY2025 annual figure was 0.83, down 14.63% from the prior year.
- Equity Ratio came in at 0.83 for Q4 2025 at Revium Rx, down from 0.97 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.97 in Q4 2024 to a low of 0.83 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 0.80 |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 0.32 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 0.62 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 0.15 |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 0.85 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 0.67 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 0.80 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 0.53 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 0.63 |
| 10 | Revium Rx | - | - | - | 0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.83 |
| Dec 31, 2024 | 0.97 |